Get Started:

Sutat is Head of Equities & Fixed Income, where he is responsible for the equities and fixed income listing, trading and post trade businesses and securities product sales for SGX globally. Mr Chew joined SGX in June 2007 and was appointed to the Executive Management Committee in May 2008. He is also Chairman of SGX’s Bull Charge CSR initiatives.

Prior to SGX, he was Group Head, Investment & Treasury Products at Standard Chartered Bank, where he was responsible for the strategy and development of the bank’s existing geographic franchises and new ventures for Global Wealth Management.

Before Standard Chartered Bank, Mr Chew was with OCBC Securities, where he headed the development of non-traditional investment products and services and the proprietary trading team. He began his career with DBS Bank in the Custody function and held varying portfolios in strategic planning and business development for institutional banking and private clients.

Outside of SGX, he is a Fellow of the Institute of Banking and Finance Singapore (IBF) and Chairman of IBF’s Sub-Committee for Corporate Finance, Securities & Futures. He sits on the President’s Advancement Advisory Council at the National University of Singapore and serves as industry advisor for the Government Parliamentary Committee for Finance, Trade & Industry. In addition, he serves as Chairman of Caregivers Alliance Limited (Charity), Vice-Chairman of Kaki Bukit Citizens’ Consultative Committee and on the board of Trustees for the Center for Domestic Employees.

Mr Chew graduated with a Bachelor of Arts (1st Class Honours) degree in Philosophy Politics & Economics (PPE) from Oxford University, Keble College in 1996. He also holds a Master of Arts degree from Oxford.

Jeffrey has over 14 years of corporate and capital markets experience, spanning roles in corporate development, operations management, financial communications and public affairs. He is also an active seed investor with interest in sectors such as fintech, communications, infotech, and healthtech.

He was previously Director of Strategic and Public Affairs at Singapore investment company Temasek, where he built up and led the global M&A communications function, as well as the media relations, and crisis/issues management teams. During his 8 years with Temasek, Jeffrey handled leadership communications, issue advocacy, and strategic relations in Singapore, US and China.

Jeffrey started his career in healthcare management with a leading regional healthcare platform and subsequently moved into strategic consulting, specialising in public affairs and financial communications.

Jeffrey holds an MA in International Relations and Affairs from the Fletcher School of Law and Diplomacy at Tufts University, and a BA in Mass Communication from RMIT University. He also holds an Advanced Diploma from the Singapore Institute of Purchasing and Materials Management.

Johnson Chen is Founder & CEO of global private capital raising platform CapBridge, which together with secondary trading private exchange platform 1exchange (1X), provide a holistic private capital solution for global growth companies. CapBridge and 1X are formed in partnership with Singapore Exchange (SGX).

With CapBridge and 1X, global growth companies and family businesses can accelerate their growth through intelligent primary capital raises and secure trading of shares, while remaining privately held. CapBridge and 1X provide both growth capital and integrated partial liquidity solutions for private companies and investors alike. This form a comprehensive private markets capital eco-system for deserving companies and sophisticated investors.

An active angel investor and experienced business builder, Johnson has spent over 20 years incubating and steering growth companies. Johnson has founded and listed two companies. He is the Founder and Non-executive Chairman of Clearbridge Health (SGX ticker: 1H3, Bloomberg ticker: CBH.SP), a pan-Asia precision healthcare company. Johnson is also the Founder and Non-executive Director of Biolidics (SGX ticker: 8YY, Bloomberg ticker: BLD.SP), a microfluidic based liquid biopsy tumor diagnosis company. Earlier in his career, Johnson co-founded and successfully exited two tech startups.

Johnson was one of the pioneering team members of Hong Kong based information and incumbent communications technology service company Pacific Century CyberWorks Limited (PCCW). He was subsequently appointed President of CyberWorks Ventures, PCCW’s direct investment arm where he led a team to build up and oversee a multi-million dollar investment portfolio. The youngest member of PCCW’s M&A/investment executive committee at that time, he was responsible for much of PCCW’s strategic expansion, including many of its successful acquisitions and investments.

Johnson sits on the Singapore National Research Foundation Proof-of-Concept grant panel and is a member of the Strategic Research Innovation Fund committee of NTUitive, Nanyang Technological University’s innovation and enterprise company.

As the top graduate in the officer cadet course during his National Service with the Singapore Armed Forces, Johnson was awarded the prestigious Sword of Honour by the President of Singapore.

Johnson holds a Master’s degree and a Bachelor degree in Manufacturing Engineering Tripos (MET) from the University of Cambridge, UK.

Alvin is an experienced senior investment banker with more than 20 years of extensive professional experiences in cross-border M&A, IPO, private equity, private placement, pre-IPO fundraising, etc. across the region.

Before joining CapBridge, Alvin was with the top investment bank in China – China International Capital Corporation (“CICC”) based in Beijing/Hong Kong/Singapore from April 2007 to July 2016, Credit Suisse Hong Kong from 2005 to March 2007, Ernst & Young Hong Kong from 2001 to 2005 and Arthur Andersen Malaysia 1998 to 2000.

Alvin graduated from the University of Cambridge, United Kingdom with a MPhil in Finance and awarded with a First Class Honours in B.A. (Hons) Accounting & Financial Management from University of Essex, United Kingdom. He is a Scholar of Cambridge Commonwealth Trust, as well as British Council British Scholarship.

Scott’s early banking career started in Jersey, Channel Islands with the Royal Bank of Scotland in 1985 and then he moved to Luxembourg in 1989 where he helped set up a new Private Banking and Fund Management office of Lloyds Bank.  Scott was then transferred to Singapore in order to help build the Private Banking business of Lloyds Bank in March of 1993 and has remained in Singapore since with various Private Banking and Private Wealth institutions.

As Principal Lead, Scott brings to CapBridge over 24 years of Asian working experience from the financial sector and has an excellent network of potential business opportunities and contacts in a wide range of industries spanning the globe.

Haiping oversees the implementation of all online/offline workflows of the CapBridge platform, and the overall platform experience for both investors and issuers.

Prior to CapBridge, Mr. Choo was Senior Investment Director at Clearbridge Accelerator, a strategic partner of CapBridge, where his responsibilities include VC deal sourcing, portfolio companies support and portfolio management. He previously worked in the Technology transfer department of the NUS Industry Liaison Office where he focused on innovation relating to Advance Materials. He started his career as an investment banking analyst at ReEx Capital Asia, where he specialized in the Asian Clean Energy sector.

Haiping is highly passionate about entrepreneurship, having founded two successful start-ups as an undergraduate. Haiping is also the recipient of several international business awards and holds a B.Eng (Material Science & Engineering) from the National University of Singapore.

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.